- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07715812
E-diary vs Paper Diary in Binge Eating Disorder (A-3650-0001)
A Mixed Methods, Observational, Cross-over Study of Measurement Comparability and Usability of Electronic and Paper Formats of a Binge Eating Diary
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Binge eating (BE) diary has already been successfully employed to measure binge eating behavior in clinical trials. This has been implemented using a paper diary (p-diary) completed daily in the evening. From the diary records, binge eating episodes are confirmed by a healthcare professional. Despite the advantages of electronic implementation and the clinical and research need for such a tool, no electronic diary (e-diary) has been systematically tested in comparison to paper diary through an empirical study.
The following scientific questions are to be answered with this project
- Are the paper and electronic diary formats considered measurement comparable, such that data collected using the different formats across different studies or programs could be directly comparable?
- Are there differences in usability that might limit completion rates or lead to under reporting using one or the other mode of data collection?
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Anna I Guerdjikova, PhD,LISW, PhD,LISW
- Phone Number: 5135360700
- Email: anna.guerdjikova@lindnercenter.org
Study Locations
-
-
Ohio
-
Mason, Ohio, United States, 45040
- Recruiting
- Lindner Center of Hope
-
Contact:
- Aspen Madrid, MS
- Phone Number: 5135360714
- Email: aspen.madrid@lindnercenter.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Diagnosis of Binge Eating Disorder based on The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) (5) criteria (as assessed with BED module of the structural clinical interview [SCID] (6) for DSM-5)
- Reported frequency of minimum of 2 binge episodes/week
- Age: over 18 years of age
- Ability to understand and complete self-reporting measures 5 . The subject owns a smartphone compatible with Google Play or Apple App Store and is able to download and use apps appropriately.
Exclusion Criteria:
- Comorbid psychiatric conditions requiring immediate hospitalization (as assessed with MSE)
- IInability to use smartphone or paper diary due to physical limitations or technical barriers (e.g., severe visual impairment)
- Inability to read/write in English
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: paper diary arm
subjects will complete paper diary for 2 weeks
|
complete paper diary for 2 weeks
|
|
Other: e-diary arm
subjects will complete e-diary for 2 weeks
|
The subject will complete one diary format and switch to the other after 2 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The primary endpoint is the comparison of number of binge eating episodes recorded over a 14-day period between diary formats
Time Frame: from enrollment v1,day 0 to v3,day 30
|
The primary endpoint is the comparison of number of binge eating episodes recorded over a 14-day period between diary formats
|
from enrollment v1,day 0 to v3,day 30
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- A-3650-0001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.